Report Categories
View AllRecent Articles
View All
Daily Market Overview Dow Slips 0.54 S P 500 Dips 0.08 Nasdaq Up 0.28 20260410
NMTC NeuroOne Medical Technologies Corporation reports sharp year over year revenue growth and narrower than expected losses to lift shares
Is 22nd XXII stock outperforming the market 22nd Century Group Inc delivers 988 EPS beat vs consensus estimates
What FirstSun FSUN is doing that smart investors recognize 035 20260507
SMJF SMJ International Holdings Inc gains 088 percent on Q1 2025 earnings release as investor sentiment holds steady
WHLRP Wheeler reports Q2 2024 quarterly earnings with EPS of 365 dollars as its stock posts a small postearnings gain
What Hawkins HWKN does that its rivals cannot Steady 20260508
STEX Streamex stock jumps 54 percent in a single day even as Q4 2025 earnings miss estimates by a wide margin
Vanguard SmallCap Index Fund ETF VB Top SmallCap ETF Pick Ahead of the Impending Market Great Rotation
Oil Supply Disruption Deepens as IEA Warns of Record Pace Inventory Drawdown
Immunic IMUX Stock Analysis 363 Loss Key Levels 20260515
Treasury Yields Hit OneYear High as Geopolitical Tensions and Inflation Data Weigh on Markets
Fidelity FNF Holds 4737 Direction Awaited 20260513
University of Manchester Pioneers Universal Work Placement Initiative Potentially Reshaping Higher Education
Jim Cramers Morning Meeting Buy Sell and One Stock with Potential 30 Upside
SpaceX Successfully Launches Starship Test Flight on Second Attempt
Crypto Industry Braces for the Evolving Threat of Quantum Computing
Venture Capital Turns to Boring Businesses AI and Dealmaking Reshape Accounting and Property Management
Kazatomprom Reports 17 Production Increase in Third Quarter Boosting Uranium Supply Outlook
Destination XL Group Inc DXLG Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction
Prairie Operating Co PROP Q1 2026 Earnings Wide EPS Miss Amid No Revenue
BHFAP Q1 2026 Earnings EPS Misses Estimates Shares Edge Lower
COHR Q1 2026 Earnings EPS Misses Estimates Stock Sees Marginal Decline
Fulcrum Therapeutics Q1 2026 Earnings Narrowing Losses as Pipeline Advances